Skip to main content
. 2019 Jul 26;14(7):e0219865. doi: 10.1371/journal.pone.0219865

Fig 2.

Fig 2

A-B. Random effects meta-analysis for (A1) progress rate to IM, (A2) progress rate to Dys, (A3) regress proportion, (A4) persistence proportion in GA patients, and for (B1) progress rate to Dys, (B2) regress proportion, (B3) persistence proportion in IM patients with 95% CI.